I ran this by an epidemiologist friend and they pointed out that SARS-CoV-2 is mutating fairly quickly, so wide deployment of low-effectiveness vaccines (possibly including this one) would encourage the emergence and spread of vaccine-resistant strains of the virus.
This might become a big problem because vaccines are being rolled out whilst there is a lot of the virus circulating in the community.
I ran this by an epidemiologist friend and they pointed out that SARS-CoV-2 is mutating fairly quickly, so wide deployment of low-effectiveness vaccines (possibly including this one) would encourage the emergence and spread of vaccine-resistant strains of the virus.
This might become a big problem because vaccines are being rolled out whilst there is a lot of the virus circulating in the community.
That’s only an issue if the low effectiveness vaccine mainly targets the spike protein and targets it in ways that the vaccine can mutate out of.
In contrast to the approved vaccines this vaccine is designed to make it harder for the virus to become resistent to it.
How sure are you that this believe is correct?
There are multiple claims here, if you want to know something specific ask a more specific question.